Revolutionary Plasma Technology from Presspart. Presspart has launched a new and innovative sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters.
View white paper
Presspart White Papers
Latest Presspart Products
NEW Presspart's Plamsa Technology
Presspart has launched a new and revolutionary sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters. The new Presspart Plasma Coating and Presspart Plasma Treatment improves the surface energy performance of an MDI canister, thus helping to prevent the active content of a drug formulation sticking to the canister wall. This ensures that the patient receives the prescribed dose and solves an inherent problem present within many of today’s metered dose inhalers. There’s also the added benefit of enhanced drug stability performance, in formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf life.
Products
Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
